4
Changes in Ownership
Xenon Pharmaceuticals Inc. Filed Acc 0001209191-19-049864
Director sold 23 shares at $9.31 ($214)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| AZAB MOHAMMAD Director | 2019-09-13 | Sale | −23 | $9.31 | $214 | 57,561 | D: show line 1 in the form |
| Open-market sales · 23 sh · avg $9.31 · $214 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| AZAB MOHAMMAD Director | 2019-09-16 | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | D: show line 2 in the form |
Loading xslF345X03/doc4.xml…